Treatment with glyburide increased the incidence of severe neonatal hypoglycemia compared to treatment with insulin, but there was no statistically significant difference [RR, 4.67; 95%CI, 0.80 to 27.22; p = 0.09]. This evidence concerns the gene INS and Neonatal hypoglycemia.